Takeda inks a licensing deal with Keros for elritercept, a late-stage anemia drug, and plans a Phase 3 trial in ...

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

The outlay, plus up to $1.1 billion in milestones, has secured Takeda ex-China rights to a molecule that could compete with ...

Takeda ( TSE:4502/NYSE:TAK ) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize ...

For people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally ...

The oral solution offers precise dosing, benefiting patients with swallowing difficulties or requiring tailored dosing.

Bempedoic acid has a novel mechanism of action that inhibits a cholesterol synthesis pathway by acting on ATP (adenosine triphosphate) citrate lyase, a citrate-degrading enzyme in the liver. Bempedoic ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

Maintenance: 100-200 mcg IM monthly. In Folic Acid deficiency Folate-deficient megaloblastic anemia due to dietary insufficiency or antiepileptic drugs: 5 mg/day for 4 months Malabsorption: Up to 15 ...

The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

These meds, called fertility drugs, work by causing your body to release hormones that trigger or regulate ovulation — the release of an egg from your ovary. Even if you already use another ...